Stock listing

NASDAQ:FLGT Fulgent Genetics, Inc. Stock

Home listing (NASDAQ) of Fulgent Genetics, Inc.

Follow Fulgent Genetics, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:FLGT

$24.12 USD -1.01 (-4.0%)

Close on Nov 20, 2026

Past year -16.2% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$23.88 – $24.79 USDNov 20, 2026
Volume
322,967 sharesNov 20, 2026
Market cap
$673.9M USDAt the close on Nov 20, 2026 · price × 27.94M shares outstanding
52-week range
$13.46 – $31.04 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$7.12M USDMedian day 297,600 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Fulgent Genetics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:FLGT · Home$24.12 USD-1.01 (-4.0%)322,967$24.12$24.79$23.88$25.13Close on Nov 20, 2026
Frankfurt:7F0€22.40 EUR-0.60 (-2.6%)—€22.40€22.40€22.40€23.00Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:FLGT · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$24.12-1.01-4.0%$24.12$24.79$23.88322,967
$25.13+0.92+3.8%$24.08$25.49$23.84392,965
$24.21+0.135+0.6%$24.12$24.23$23.39274,556
$24.08-0.585-2.4%$24.47$24.47$23.88267,143
$24.66-0.19-0.8%$24.85$25.01$24.35262,096
$24.85-0.85-3.3%$25.41$25.73$24.55287,387
$25.70-0.08-0.3%$26.00$26.73$25.29494,573
$25.78-0.37-1.4%$26.50$27.41$25.53616,856
$26.15+2.41+10.2%$23.86$26.66$23.32973,963
$23.74+5.08+27.2%$20.47$23.85$19.641,097,400
$18.66-1.02-5.2%$19.59$19.63$18.44388,300
$19.68+0.31+1.6%$19.74$19.99$19.30364,000
$19.37+0.08+0.4%$19.41$19.73$19.19284,400
$19.29-1.33-6.5%$20.82$20.84$19.05339,400
$20.62-1.06-4.9%$21.50$21.77$20.54201,400
$21.68+0.16+0.7%$21.64$21.72$21.14210,100
$21.52+0.82+4.0%$20.64$21.52$20.64397,600
$20.70+0.48+2.4%$20.19$20.73$20.08355,600
$20.22+0.12+0.6%$20.14$20.53$20.14191,200
$20.10+0.11+0.6%$19.85$20.28$19.65240,100
$19.99-0.14-0.7%$20.08$20.24$19.30278,900
$20.13-0.20-1.0%$20.21$20.50$19.98193,800
$20.33+0.23+1.1%$20.19$20.67$19.96161,000
$20.10+0.29+1.5%$19.89$20.39$19.89212,700
$19.81-1.53-7.2%$21.45$21.49$19.73443,400
$21.34+0.33+1.6%$21.05$21.50$20.86139,700
$21.01-0.05-0.2%$20.84$21.44$20.65352,100
$21.06-0.41-1.9%$21.47$21.60$21.06201,300
$21.47-0.27-1.2%$21.74$21.80$21.22228,000
$21.74+0.92+4.4%$20.82$21.79$20.82253,900
$20.82+0.25+1.2%$20.49$20.88$19.82427,900
$20.57-0.010.0%$20.48$20.70$19.90298,300
$20.58-1.87-8.3%$22.43$22.78$20.46368,600
$22.45+0.97+4.5%$21.37$22.47$21.28308,000
$21.48+0.18+0.8%$21.64$21.64$21.07297,600
$21.30-0.72-3.3%$21.99$22.05$21.12338,200
$22.02-0.06-0.3%$22.07$22.25$21.69273,500
$22.08-0.28-1.3%$22.29$22.59$21.88234,800
$22.36+0.16+0.7%$21.99$22.39$21.83248,600
$22.20+0.65+3.0%$21.69$22.25$21.36247,000
$21.55+0.28+1.3%$21.28$21.87$21.28369,600
$21.27-0.38-1.8%$21.52$21.63$21.12190,300
$21.65+0.11+0.5%$21.52$21.84$21.35252,300
$21.54-0.15-0.7%$21.93$21.93$21.01348,800
$21.69-0.16-0.7%$21.70$21.88$21.41669,200
$21.85+0.22+1.0%$21.59$21.88$21.37312,000
$21.63+0.35+1.6%$21.31$21.81$21.20328,300
$21.28+0.63+3.1%$20.60$21.31$20.60479,900
$20.65+0.20+1.0%$20.46$20.80$20.10336,300
$20.45+0.33+1.6%$20.30$20.52$19.86380,500
$20.12+0.27+1.4%$19.69$20.16$19.46337,300
$19.85-0.35-1.7%$20.09$20.10$19.61369,900
$20.20+0.47+2.4%$19.55$20.23$19.44375,000
$19.73+0.08+0.4%$19.54$19.86$19.38225,000
$19.65-0.39-1.9%$20.11$20.34$19.46283,500
$20.04+0.45+2.3%$19.59$20.20$19.59412,400
$19.59+0.22+1.1%$19.29$19.85$19.29285,600
$19.37-0.24-1.2%$19.42$19.54$19.04407,400
$19.61-0.34-1.7%$19.88$19.93$19.49192,500
$19.95+0.14+0.7%$19.74$20.21$19.74212,500
$19.81-0.14-0.7%$19.96$20.00$19.75170,800
$19.95+0.50+2.6%$19.50$20.06$19.35185,400
$19.45-0.45-2.3%$19.89$19.91$19.19259,900
$19.90-0.02-0.1%$20.01$20.04$19.57324,000
$19.92+0.18+0.9%$19.60$20.52$19.58203,700
Ticker
NASDAQ:FLGT
Asset type
Stock
Sector
Health care
Industry
Health care services
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Fulgent Genetics, Inc. news

Fulgent Genetics, Inc. on 6ix

Sector
Health care
Industry
Health care services
News releases
14 in the last 12 months · 128 in all · newest Nov 5, 2026 · oldest 2019
Calls
27 calls with a replay · 27 with a transcript · latest Nov 5, 2026
Decks
24 decks · latest Nov 5, 2026

Where Fulgent Genetics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:FLGT · Home listing · This pageNASDAQUnited StatesUSD
LS Exchange:A2AS4NLS ExchangeGermanyEUR
Lang & Schwarz:A2AS4NLang & SchwarzGermanyEUR
BMV:FLGTBMVMexicoMXN
BIVA:FLGTBIVAMexicoMXN
gettex:7F0gettexGermanyEUR
BOATS:FLGTBOATSUnited StatesUSD
Frankfurt:7F0FrankfurtGermanyEUR
Dusseldorf:7F0DusseldorfGermanyEUR
Munich:7F0MunichGermanyEUR
Stuttgart:7F0StuttgartGermanyEUR
Tradegate:7F0TradegateGermanyEUR

Valuation

EV/sales 1.2× against a median of 1.5×: 2nd lowest of 11 Health care services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$381.6M USD
P/E
Loss
EV/sales
1.2×
EV/EBITDA
Negative EBITDA
Price/book
0.7×
Gross margin
33.8%
Operating margin
−39.2%
Net margin
−27.5%
Debt to equity
0.0×
Beta vs S&P 500
0.99

Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Fulgent Genetics, Inc. · NASDAQ:FLGTUS$673.9MUS$381.6Mn/a1.2×n/a0.7×−27.5%0.0×0.99
Gushengtang Holdings Limited · HKEX:2273US$716.5MUS$752.4M13.5×1.5×7.9×2.5×10.9%0.8×n/a
Nephrocare Health Services Limited · NSE:NEPHROPLUSUS$711.7MUS$656.6M51.5×5.5×24.8×5.5×11.5%0.0×n/a
Phreesia, Inc. · NYSE:PHRUS$708.2MUS$634.7M67.8×1.3×12.8×1.9×2.1%0.0×0.42
Jinxin Fertility Group Ltd. · HKEX:1951US$692.5MUS$1.02Bn/a2.6×12.6×0.5×−36.9%0.3×n/a
Xunfei Healthcare Technology Co., Ltd. · HKEX:2506US$682.0MUS$664.6Mn/a4.8×n/a5.3×−7.1%0.1×n/a
Bright Eye Hospital Group Co., Ltd. Class A · SZSE:301239US$671.3MUS$637.2M60.6×1.4×n/a2.1×2.4%0.1×n/a
Shanghai Runda Medical Technology Co., Ltd. Class A · SSE:603108US$663.4MUS$591.1Mn/a0.6×n/a1.2×−8.6%0.1×n/a
PT Metro Healthcare Indonesia Tbk · IDX:CAREUS$651.9MUS$684.4M1,733×21.8×n/a3.9×1.2%0.5×n/a
Wuxi Commercial Mansion Grand Orient Co., Ltd. Class A · SSE:600327US$641.4MUS$572.2Mn/a1.5×n/a1.6×−11.5%0.0×n/a
Ramkhamhaeng Hospital Public Co. Ltd. · SET:RAMUS$625.3MUS$904.8M7.7×1.5×8.4×0.9×13.5%0.5×n/a
Median of the othersUS$676.6MUS$660.6M56.0×1.5×12.6×2.0×1.6%0.1×0.42

Forecasts

1 hold · Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.

Price target
25.00 USD · Analysts' mean
EPS, year to Dec 2026
-1.70 · 1 analyst
Revenue, year to Dec 2026
335.1M · 1 analyst

Team and board

Officers

OfficerRole
Ming HsiehChairman of our Board of Directors and Chief Executive Officer

Board

DirectorRole
Ming HsiehChairman of our Board of Directors and Chief Executive Officer
Linda MarshDirector
Michael NohaileDirector
Reggie GrovesDirector

Events

Calls

CallWhenStatus
Fulgent Genetics (NASDAQ:FLGT) Q3 2026 Earnings CallThu, Nov 05, 2026 · 4:30 PM ETReplay
Fulgent Genetics (NASDAQ:FLGT) Q2 2026 Earnings CallThu, Jul 30, 2026 · 4:30 PM ETReplay
Fulgent Genetics (NASDAQ:FLGT) Q1 2026 Earnings CallFri, May 01, 2026 · 8:30 AM ETReplay
Fulgent Genetics (NASDAQ:FLGT) Q4 2025 Earnings CallFri, Feb 27, 2026 · 8:30 AM ETReplay
Fulgent Genetics (NASDAQ:FLGT) Q3 2025 Earnings CallFri, Nov 07, 2025 · 8:30 AM ETReplay
Fulgent Genetics (NASDAQ:FLGT) Q2 2025 Earnings CallFri, Aug 01, 2025 · 8:30 AM ETReplay
Fulgent Genetics (NASDAQ:FLGT) Q1 2025 Earnings CallFri, May 02, 2025 · 8:30 AM ETReplay
Fulgent Genetics (NASDAQ:FLGT) Q4 2024 Earnings CallFri, Feb 28, 2025 · 8:30 AM ETReplay
Fulgent Genetics (NASDAQ:FLGT) Q3 2024 Earnings CallFri, Nov 08, 2024 · 8:30 AM ETReplay
Fulgent Genetics (NASDAQ:FLGT) Q2 2024 Earnings CallFri, Aug 02, 2024 · 8:30 AM ETReplay
All 27 calls
CallWhenStatus
Fulgent Genetics (NASDAQ:FLGT) Q1 2024 Earnings CallFri, May 03, 2024 · 8:30 AM ETReplay
Fulgent Genetics (NASDAQ:FLGT) Q4 2023 Earnings CallWed, Feb 28, 2024 · 8:30 AM ETReplay
Fulgent Genetics (NASDAQ:FLGT) Q3 2023 Earnings CallFri, Nov 03, 2023 · 8:30 AM ETReplay
Fulgent Genetics (NASDAQ:FLGT) Q2 2023 Earnings CallFri, Aug 04, 2023 · 8:30 AM ETReplay
Fulgent Genetics (NASDAQ:FLGT) Q1 2023 Earnings CallFri, May 05, 2023 · 8:30 AM ETReplay
Fulgent Genetics (NASDAQ:FLGT) Q4 2022 Earnings CallTue, Feb 28, 2023 · 4:30 PM ETReplay
Fulgent Genetics (NASDAQ:FLGT) Q3 2022 Earnings CallMon, Nov 07, 2022 · 4:30 PM ETReplay
Fulgent Genetics (NASDAQ:FLGT) Q2 2022 Earnings CallThu, Aug 04, 2022 · 4:30 PM ETReplay
Fulgent Genetics (NASDAQ:FLGT) Q1 2022 Earnings CallTue, May 03, 2022 · 4:30 PM ETReplay
Fulgent Genetics (NASDAQ:FLGT) Q4 2021 Earnings CallWed, Feb 23, 2022 · 4:30 PM ETReplay
Fulgent Genetics (NASDAQ:FLGT) Q3 2021 Earnings CallTue, Nov 09, 2021 · 4:30 PM ETReplay
Fulgent Genetics (NASDAQ:FLGT) Q2 2021 Earnings CallThu, Aug 05, 2021 · 4:30 PM ETReplay
Fulgent Genetics (NASDAQ:FLGT) Q1 2021 Earnings CallThu, May 06, 2021 · 4:30 PM ETReplay
Fulgent Genetics (NASDAQ:FLGT) Q4 2020 Earnings CallThu, Mar 04, 2021 · 4:30 PM ETReplay
Fulgent Genetics (NASDAQ:FLGT) Q3 2020 Earnings CallMon, Nov 09, 2020 · 3:30 PM ETReplay
Fulgent Genetics (NASDAQ:FLGT) Q2 2020 Earnings CallTue, Aug 04, 2020 · 4:30 PM ETReplay
Fulgent Genetics (NASDAQ:FLGT) Q1 2020 Earnings CallMon, May 04, 2020 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 5, 2026 · After close+27.2%
Q2 2026Jul 30, 2026 · After close−18.1%
Q1 2026May 1, 2026 · Before open−7.0%
Q4 2025Feb 26, 2026−34.9%
Q3 2025Nov 7, 2025 · Before open+18.1%
Q2 2025Aug 1, 2025 · Before open+7.9%
Q1 2025May 2, 2025 · Before open+19.1%
Q4 2024Feb 26, 2025 · Before open−0.3%
Q3 2024Nov 8, 2024 · Before open−11.8%
Q2 2024Aug 2, 2024 · Before open+6.3%
All 20 quarters
QuarterResultsShare move
Q1 2024May 3, 2024 · Before open+1.2%
Q4 2023Feb 28, 2024 · Before open−8.1%
Q3 2023Nov 3, 2023 · Before open+13.2%
Q2 2023Aug 4, 2023 · Before open−3.0%
Q1 2023May 5, 2023 · Before open+19.0%
Q4 2022Feb 28, 2023 · After close−2.9%
Q3 2022Nov 7, 2022 · After close−2.3%
Q2 2022Aug 4, 2022 · After close−6.1%
Q1 2022May 3, 2022 · After close+3.6%
Q4 2021Feb 23, 2022 · After close+2.2%

Open Events

Decks

DeckKindSlidesDate
Q3 2026 Earnings PresentationEarnings44 slidesNov 5, 2026
Q2 2026 Earnings PresentationEarnings49 slidesJul 30, 2026
Q1 2026 Earnings PresentationEarnings52 slidesMay 1, 2026
Q4 2025 Earnings PresentationEarnings51 slidesFeb 27, 2026
Q3 2025 Earnings PresentationEarnings51 slidesNov 7, 2025
Q2 2025 Earnings PresentationEarnings36 slidesAug 1, 2025
Q1 2025 Earnings PresentationEarnings36 slidesMay 2, 2025
Investor Presentation (February 2025)Investor deck39 slidesFeb 28, 2025
Q3 2024 Earnings PresentationEarnings39 slidesNov 8, 2024
Q2 2024 Earnings PresentationEarnings37 slidesAug 2, 2024
All 24 decks
DeckKindSlidesDate
Q1 2024 Earnings PresentationEarnings37 slidesMay 3, 2024
Investor Presentation (February 2024)Investor deck37 slidesFeb 28, 2024
Investor Presentation (November 2023)Investor deck37 slidesNov 3, 2023
Investor Presentation (August 2023)Investor deck37 slidesAug 4, 2023
Investor Presentation (May 2023)Investor deck36 slidesMay 5, 2023
Raymond James & Associates' 44th Annual Institutional Investors Conference (March 2023)Conference25 slidesMar 7, 2023
Investor Presentation (February 2023)Investor deck36 slidesFeb 28, 2023
Investor Presentation (November 2022)Investor deck28 slidesNov 7, 2022
Q3 2022 Earnings PresentationEarnings20 slidesNov 7, 2022
Q2 2022 Earnings PresentationEarnings28 slidesAug 4, 2022
Q1 2022 Earnings PresentationEarnings28 slidesMay 3, 2022
Q4 2021 Earnings PresentationEarnings29 slidesFeb 23, 2022
Q3 2021 Earnings PresentationEarnings28 slidesNov 9, 2021
Q2 2021 Earnings PresentationEarnings28 slidesAug 9, 2021

Open Decks

IPO

Priced at US$9.00 a share on Sep 28, 2016.

Price
US$9.00 a share
Shares offered
4,200,000 shares of common stock
Offering size
US$37.8 million
Underwriters' option
Up to 630,000 more shares
Underwriters
Credit Suisse, Piper Jaffray, Raymond James, BTIG · In the order on the cover
Shares delivered
On or about Oct 4, 2016

Steps

StepWhen
Draft sent to the SEC in confidenceJun 9, 2016
Filed publiclySep 2, 2016
Amended 3 timesNewest Sep 28, 2016
Shares registered with an exchangeSep 26, 2016
Declared effective by the SECSep 28, 2016
Final prospectus, with the priceSep 29, 2016

Open IPO · From the cover of the final prospectus (424B4) filed Sep 29, 2016

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue322.7M283.5M289.2M619.0M992.6M421.7M32.5M21.4M18.7M18.3M
Cost of revenue191.8M176.3M184.8M252.1M215.5M89.8M14.1M10.7M8.55M6.72M
Gross profit130.9M107.2M104.5M366.9M777.1M331.9M18.4M10.7M10.2M11.6M
Research and development53.9M48.8M41.4M28.9M24.2M11.6M6.54M5.53M4.22M3.56M
Selling, general and administrative116.7M88.1M89.0M111.1M50.7M15.2M6.41M5.54M5.13M4.61M
Operating income-91.1M-73.9M-195.5M178.5M676.0M290.2M-428.0K-5.07M-3.48M918.0K
Depreciation and amortization24.1M24.9M26.1M32.7M11.0M2.96M2.11M2.16M1.73M1.17M
EBITDA-67.0M-49.0M-169.4M211.2M687.0M293.1M1.68M-2.91M-1.75M2.09M
Interest expense75.0K-170.0K488.0K346.0K117.0K20.0K2.17M005.39M
Income before tax-70.0M-52.0M-174.1M184.0M677.3M291.7M409.0K-4.64M-3.00M-4.47M
Income tax-8.39M-8.14M1.15M42.1M174.8M72.5M43.0K36.0K-1.01M920.0K
Net income-60.5M-42.7M-167.8M143.4M507.4M214.3M-411.0K-5.61M-2.51M-5.35M
Earnings per share, basic-1.95-1.38-5.664.8716.827.61-0.02-0.31-0.14-0.30

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents50.2M55.1M97.5M79.5M164.9M87.4M12.0M6.74M6.49M7.90M
Short-term investments285.9M203.0M326.7M446.7M285.6M211.9M16.3M24.3M20.0M38.6M
Receivables84.8M69.0M51.1M52.7M138.9M183.9M6.55M5.95M4.00M4.36M
Inventory10.6M8.38M5.83M4.28M12.2M16.5M277.0K314.0K231.0K322.0K
Current assets550.5M353.6M507.8M627.9M612.0M523.6M37.1M39.5M32.9M26.1M
Property, plant and equipment112.5M105.5M83.5M81.4M62.3M40.2M5.97M6.45M7.27M6.23M
Goodwill25.1M22.1M22.1M143.0M50.9M000
Total assets1.21B1.22B1.24B1.39B1.28B700.5M88.8M53.9M57.2M58.0M
Accounts payable18.7M18.4M15.4M23.1M20.5M26.5M1.58M1.31M2.09M2.76M
Current liabilities85.0M72.9M73.0M88.1M105.3M130.1M3.72M2.74M3.00M3.32M
Long-term debt1.96M2.49M2.96M3.37M00
Total debt7.68M8.47M15.3M38.9M21.3M15.9M2.68M
Total liabilities106.8M90.8M102.0M116.2M112.8M131.1M5.98M2.75M3.01M3.56M
Shareholders' equity1.11B1.13B1.14B1.27B1.16B569.4M82.8M51.2M54.2M54.5M
Shares outstanding31.1M30.8M29.7M29.4M30.2M28.2M21.5M18.2M17.8M17.7M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-101.6M21.1M27.0M253.5M538.6M140.6M5.52M-675.0K1.33M4.41M
Capital spending-22.6M-40.3M-22.2M-18.8M-23.8M-35.1M-1.18M-2.32M-2.90M-3.79M
Free cash flow-124.2M-19.3M4.80M234.7M514.8M105.5M4.33M-3.00M-1.56M617.0K
Cash from investing111.4M-58.4M38.9M-261.3M-546.5M-326.4M-29.0M950.0K-2.05M-42.8M
Cash from financing-14.8M-4.85M-47.8M-77.1M85.4M261.3M28.8M15.0K-770.0K45.8M
Dividends paid-4.16M-15.0M0-4.59M
Share buybacks-10.9M-225.0K-25.1M-74.3M-4.16M-62.0K-21.0K15.0K31.0K-6.59M
Change in cash-4.95M-42.2M18.0M-85.4M77.5M75.5M5.23M246.0K-1.41M7.40M

Open Financials

Filings

FilingDateTypeFiled with
8-K · Current reportNov 18, 2026Material contractSEC
10-Q · Quarterly reportNov 5, 2026Quarterly reportSEC
8-K · Current reportNov 5, 2026ResultsSEC
4 · Change in ownershipOct 28, 2026Insider tradeSEC
4 · Change in ownershipOct 28, 2026Insider tradeSEC
4 · Change in ownershipOct 28, 2026Insider tradeSEC
4 · Change in ownershipSep 3, 2026Insider tradeSEC
4 · Change in ownershipSep 3, 2026Insider tradeSEC
4 · Change in ownershipSep 3, 2026Insider tradeSEC
4 · Change in ownershipSep 3, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
144 · Notice of proposed saleSep 2, 2026Other filingsSEC
144 · Notice of proposed saleSep 2, 2026Other filingsSEC
4 · Change in ownershipAug 28, 2026Insider tradeSEC
4 · Change in ownershipAug 28, 2026Insider tradeSEC
4 · Change in ownershipAug 28, 2026Insider tradeSEC
4 · Change in ownershipAug 28, 2026Insider tradeSEC
144 · Notice of proposed saleAug 27, 2026Other filingsSEC
144 · Notice of proposed saleAug 27, 2026Other filingsSEC
10-Q · Quarterly reportJul 30, 2026Quarterly reportSEC
8-K · Current reportJul 30, 2026ResultsSEC
4 · Change in ownershipJul 28, 2026Insider tradeSEC
4 · Change in ownershipJul 28, 2026Insider tradeSEC
4 · Change in ownershipJul 28, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
144 · Notice of proposed saleJun 2, 2026Other filingsSEC
8-K · Current reportJun 1, 2026Current reportSEC
4 · Change in ownershipMay 28, 2026Insider tradeSEC
4 · Change in ownershipMay 28, 2026Insider tradeSEC
4 · Change in ownershipMay 28, 2026Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedMay 27, 2026Big-stake noticeSEC
4 · Change in ownershipMay 27, 2026Insider tradeSEC
8-K · Current reportMay 21, 2026Current reportSEC
4 · Change in ownershipMay 18, 2026Insider tradeSEC
4 · Change in ownershipMay 18, 2026Insider tradeSEC
4 · Change in ownershipMay 18, 2026Insider tradeSEC
S-8 · Registration statement for employee plansMay 14, 2026Offer documentSEC
8-K · Current reportMay 14, 2026Management or board changeSEC
10-Q · Quarterly reportMay 1, 2026Quarterly reportSEC
8-K · Current reportMay 1, 2026ResultsSEC
4 · Change in ownershipApr 28, 2026Insider tradeSEC
4 · Change in ownershipApr 28, 2026Insider tradeSEC
4 · Change in ownershipApr 28, 2026Insider tradeSEC
4/A · Change in ownership, amendedMar 31, 2026Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedMar 31, 2026Big-stake noticeSEC
ARS · Annual report to shareholdersMar 31, 2026Annual reportSEC
DEFA14A · Additional proxy materialMar 31, 2026Meeting noticeSEC
DEF 14A · Proxy statementMar 31, 2026Meeting noticeSEC
8-K · Current reportMar 17, 2026Acquisition or disposalSEC
4 · Change in ownershipMar 11, 2026Insider tradeSEC
4 · Change in ownershipMar 2, 2026Insider tradeSEC
4 · Change in ownershipMar 2, 2026Insider tradeSEC
4 · Change in ownershipMar 2, 2026Insider tradeSEC
4 · Change in ownershipMar 2, 2026Insider tradeSEC
10-K · Annual reportFeb 27, 2026Annual reportSEC
8-K · Current reportFeb 27, 2026ResultsSEC
4 · Change in ownershipFeb 25, 2026Insider tradeSEC
4 · Change in ownershipFeb 25, 2026Insider tradeSEC
4 · Change in ownershipFeb 25, 2026Insider tradeSEC
4 · Change in ownershipFeb 25, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 4, 2026Big-stake noticeSEC
4 · Change in ownershipJan 28, 2026Insider tradeSEC
4 · Change in ownershipJan 28, 2026Insider tradeSEC
4 · Change in ownershipJan 28, 2026Insider tradeSEC
8-K · Current reportDec 22, 2025Material contractSEC
4 · Change in ownershipDec 3, 2025Insider tradeSEC
4 · Change in ownershipDec 3, 2025Insider tradeSEC
4 · Change in ownershipDec 3, 2025Insider tradeSEC
4 · Change in ownershipDec 1, 2025Insider tradeSEC
4 · Change in ownershipDec 1, 2025Insider tradeSEC
144 · Notice of proposed saleDec 1, 2025Other filingsSEC
144 · Notice of proposed saleDec 1, 2025Other filingsSEC
4 · Change in ownershipDec 1, 2025Insider tradeSEC
4 · Change in ownershipDec 1, 2025Insider tradeSEC
144 · Notice of proposed saleNov 26, 2025Other filingsSEC
144 · Notice of proposed saleNov 26, 2025Other filingsSEC
4 · Change in ownershipNov 25, 2025Insider tradeSEC
4 · Change in ownershipNov 25, 2025Insider tradeSEC
4 · Change in ownershipNov 25, 2025Insider tradeSEC
4 · Change in ownershipNov 25, 2025Insider tradeSEC
144 · Notice of proposed saleNov 24, 2025Other filingsSEC
144 · Notice of proposed saleNov 24, 2025Other filingsSEC
4 · Change in ownershipNov 21, 2025Insider tradeSEC
144 · Notice of proposed saleNov 19, 2025Other filingsSEC
10-Q · Quarterly reportNov 7, 2025Quarterly reportSEC
8-K · Current reportNov 7, 2025ResultsSEC
4 · Change in ownershipOct 28, 2025Insider tradeSEC
4 · Change in ownershipOct 28, 2025Insider tradeSEC
4 · Change in ownershipOct 28, 2025Insider tradeSEC
8-K · Current reportOct 20, 2025Current reportSEC
4 · Change in ownershipSep 3, 2025Insider tradeSEC
4 · Change in ownershipSep 3, 2025Insider tradeSEC
4 · Change in ownershipSep 3, 2025Insider tradeSEC
144 · Notice of proposed saleSep 3, 2025Other filingsSEC
144 · Notice of proposed saleSep 3, 2025Other filingsSEC
4 · Change in ownershipAug 28, 2025Insider tradeSEC
4 · Change in ownershipAug 28, 2025Insider tradeSEC
4 · Change in ownershipAug 28, 2025Insider tradeSEC
4 · Change in ownershipAug 28, 2025Insider tradeSEC
144/A · Notice of proposed sale, amendedAug 27, 2025Other filingsSEC
144/A · Notice of proposed sale, amendedAug 27, 2025Other filingsSEC
144 · Notice of proposed saleAug 27, 2025Other filingsSEC
144 · Notice of proposed saleAug 27, 2025Other filingsSEC
4 · Change in ownershipAug 26, 2025Insider tradeSEC
4 · Change in ownershipAug 26, 2025Insider tradeSEC
4 · Change in ownershipAug 26, 2025Insider tradeSEC
4 · Change in ownershipAug 26, 2025Insider tradeSEC
144 · Notice of proposed saleAug 25, 2025Other filingsSEC
4 · Change in ownershipAug 5, 2025Insider tradeSEC
10-Q · Quarterly reportAug 1, 2025Quarterly reportSEC
8-K · Current reportAug 1, 2025ResultsSEC
4 · Change in ownershipJul 29, 2025Insider tradeSEC
4 · Change in ownershipJul 29, 2025Insider tradeSEC
4 · Change in ownershipJul 29, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 29, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 29, 2025Big-stake noticeSEC
4 · Change in ownershipJun 11, 2025Insider tradeSEC
4 · Change in ownershipJun 3, 2025Insider tradeSEC
4 · Change in ownershipJun 3, 2025Insider tradeSEC
4 · Change in ownershipJun 3, 2025Insider tradeSEC
144 · Notice of proposed saleJun 2, 2025Other filingsSEC
4 · Change in ownershipMay 28, 2025Insider tradeSEC
4 · Change in ownershipMay 28, 2025Insider tradeSEC
4 · Change in ownershipMay 28, 2025Insider tradeSEC
4 · Change in ownershipMay 28, 2025Insider tradeSEC
4 · Change in ownershipMay 19, 2025Insider tradeSEC
4 · Change in ownershipMay 19, 2025Insider tradeSEC
4 · Change in ownershipMay 19, 2025Insider tradeSEC
8-K · Current reportMay 15, 2025Meeting outcomeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 13, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 6, 2025Big-stake noticeSEC
4 · Change in ownershipMay 5, 2025Insider tradeSEC
4 · Change in ownershipMay 2, 2025Insider tradeSEC
10-Q · Quarterly reportMay 2, 2025Quarterly reportSEC
8-K · Current reportMay 2, 2025ResultsSEC
4 · Change in ownershipApr 29, 2025Insider tradeSEC
4 · Change in ownershipApr 29, 2025Insider tradeSEC
4 · Change in ownershipApr 29, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedApr 3, 2025Big-stake noticeSEC
ARS · Annual report to shareholdersMar 26, 2025Annual reportSEC
DEFA14A · Additional proxy materialMar 26, 2025Meeting noticeSEC
DEF 14A · Proxy statementMar 25, 2025Meeting noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 21, 2025Big-stake noticeSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4/A · Change in ownership, amendedMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
10-K · Annual reportFeb 28, 2025Annual reportSEC
8-K · Current reportFeb 28, 2025ResultsSEC
4 · Change in ownershipFeb 27, 2025Insider tradeSEC
4 · Change in ownershipFeb 27, 2025Insider tradeSEC
4 · Change in ownershipFeb 27, 2025Insider tradeSEC
4 · Change in ownershipFeb 27, 2025Insider tradeSEC
4 · Change in ownershipFeb 25, 2025Insider tradeSEC
4 · Change in ownershipFeb 25, 2025Insider tradeSEC
4 · Change in ownershipFeb 25, 2025Insider tradeSEC
4 · Change in ownershipFeb 25, 2025Insider tradeSEC
SCHEDULE 13G · Big-stake noticeFeb 7, 2025Big-stake noticeSEC
4 · Change in ownershipFeb 4, 2025Insider tradeSEC
4 · Change in ownershipFeb 3, 2025Insider tradeSEC
4 · Change in ownershipJan 28, 2025Insider tradeSEC
4 · Change in ownershipJan 28, 2025Insider tradeSEC
4 · Change in ownershipJan 28, 2025Insider tradeSEC
SCHEDULE 13G · Big-stake noticeJan 8, 2025Big-stake noticeSEC
4 · Change in ownershipDec 4, 2024Insider tradeSEC
4 · Change in ownershipDec 4, 2024Insider tradeSEC
4 · Change in ownershipDec 4, 2024Insider tradeSEC
144 · Notice of proposed saleDec 2, 2024Other filingsSEC
144 · Notice of proposed saleDec 2, 2024Other filingsSEC
4 · Change in ownershipNov 27, 2024Insider tradeSEC
4 · Change in ownershipNov 27, 2024Insider tradeSEC
4 · Change in ownershipNov 27, 2024Insider tradeSEC
4 · Change in ownershipNov 27, 2024Insider tradeSEC
144 · Notice of proposed saleNov 25, 2024Other filingsSEC
144 · Notice of proposed saleNov 25, 2024Other filingsSEC
144 · Notice of proposed saleNov 25, 2024Other filingsSEC
10-Q · Quarterly reportNov 8, 2024Quarterly reportSEC
8-K · Current reportNov 8, 2024ResultsSEC
SC 13D/A · Big-stake notice, amendedNov 5, 2024Big-stake noticeSEC
4 · Change in ownershipNov 5, 2024Insider tradeSEC
4 · Change in ownershipNov 1, 2024Insider tradeSEC
4 · Change in ownershipOct 29, 2024Insider tradeSEC
4 · Change in ownershipOct 29, 2024Insider tradeSEC
4 · Change in ownershipOct 29, 2024Insider tradeSEC
4 · Change in ownershipSep 5, 2024Insider tradeSEC
4 · Change in ownershipSep 5, 2024Insider tradeSEC
4 · Change in ownershipSep 5, 2024Insider tradeSEC
144 · Notice of proposed saleSep 3, 2024Other filingsSEC
144 · Notice of proposed saleSep 3, 2024Other filingsSEC
4 · Change in ownershipAug 29, 2024Insider tradeSEC
4 · Change in ownershipAug 29, 2024Insider tradeSEC
4 · Change in ownershipAug 29, 2024Insider tradeSEC
4 · Change in ownershipAug 29, 2024Insider tradeSEC
144 · Notice of proposed saleAug 27, 2024Other filingsSEC
4 · Change in ownershipAug 6, 2024Insider tradeSEC
4 · Change in ownershipAug 6, 2024Insider tradeSEC
4 · Change in ownershipAug 5, 2024Insider tradeSEC

This page holds 200 of 671 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Fulgent Genetics, Inc.’s releases · as of Nov 2, 2026

Common shares
27,939,000
Fully diluted
27,939,000

Fully diluted

LineSharesAs of
Common shares27,939,000Nov 2, 2026

Share count over time

CountShares
Nov 2, 202627,939,000

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueChange vs Jun 30Filed
BlackRock2.44M8.7%US$53.7M+153KNov 13, 2026
Acadian Asset Management LLC1.09M3.9%US$24M+73,038Nov 9, 2026
Vanguard1.07M3.8%US$23.5M−44,248Nov 13, 2026
Diametric Capital, LP932K3.3%US$20.5M+235KNov 16, 2026
Two Sigma929K3.3%US$20.5M+528KNov 16, 2026
Ameriprise667K2.4%US$14.7M−3,448Nov 16, 2026
Dimensional647K2.3%US$14.2M+21,270Nov 4, 2026
Jacobs Levy Equity Management, Inc583K2.1%US$12.8M−199KNov 16, 2026
State Street517K1.9%US$11.4M+18,270Nov 12, 2026
JPMorgan516K1.8%US$11.4M−240KNov 12, 2026
Show 50 holders
HolderSharesOf the companyValueChange vs Jun 30Filed
Geode Capital438K1.6%US$9.66M−82,662Nov 6, 2026
D. E. Shaw & Co., Inc.414K1.5%US$9.12M+122KNov 16, 2026
Goldman Sachs345K1.2%US$7.59M+36,601Nov 16, 2026
Schwab341K1.2%US$7.5M−10,343Nov 16, 2026
Tudor Investment Corp Et Al262K0.94%US$5.78M+181KNov 16, 2026
Peapod Lane Capital LLC211K0.75%US$4.64M−13,424Oct 22, 2026
Morgan Stanley198K0.71%US$4.35M+38,132Nov 13, 2026
Bank of America190K0.68%US$4.19M+14,603Nov 16, 2026
Connor, Clark & Lunn Investment Management Ltd.174K0.62%US$3.84M+15,223Nov 10, 2026
Northern Trust156K0.56%US$3.43M−14,351Nov 16, 2026
BNP Paribas140K0.50%US$3.09M+78,052Nov 12, 2026
Quantinno Capital Management LP138K0.50%US$3.05M+23,080Nov 13, 2026
Jump Financial, LLC133K0.48%US$2.93M+23,615Nov 13, 2026
Tcw Group Inc131K0.47%US$2.89MNo changeNov 10, 2026
Caxton Associates LLP131K0.47%US$2.89M+68,997Nov 13, 2026
Citadel125K0.45%US$2.76M−48,795Nov 16, 2026
Hennion & Walsh Asset Management, Inc.115K0.41%US$2.54M+3,780Oct 13, 2026
Allianz110K0.39%US$2.41M−44,961Nov 16, 2026
Hrt Financial LP94,7010.34%US$2.08M−135KNov 13, 2026
UBS93,2380.33%US$2.05M−127KNov 16, 2026
XTX Topco Ltd93,0740.33%US$2.05MNewNov 16, 2026
Millennium90,4840.32%US$1.99M−230KNov 16, 2026
Russell Investments Group, Ltd.85,1530.30%US$1.88M−49,985Nov 6, 2026
HSBC82,0400.29%US$1.8M+36,992Nov 16, 2026
BNY72,9520.26%US$1.61M−2,687Nov 5, 2026
Nuveen68,5300.25%US$1.51M+1,805Nov 10, 2026
Prelude Capital Management, LLC66,8160.24%US$1.47M+15,118Nov 16, 2026
AQR Capital Management LLC65,7510.24%US$1.45M−3,702Nov 16, 2026
ExodusPoint Capital Management, LP65,6060.23%US$1.44M+18,519Nov 16, 2026
Invesco64,5310.23%US$1.42M+12,048Nov 12, 2026
PDT Partners, LLC58,1380.21%US$1.28MNewNov 16, 2026
Point72 Asset Management, L.P.54,3180.19%US$1.2M−157KNov 16, 2026
Federated Hermes, Inc.49,7660.18%US$1.1M+559Nov 12, 2026
Walleye Capital LLC48,9710.18%US$1.08MNewNov 13, 2026
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.44,8020.16%US$987K+13,048Nov 16, 2026
Moore Capital Management, LP44,3900.16%US$977K−3,953Nov 16, 2026
Corient Private Wealth LP44,3760.16%US$977K−1,018Nov 16, 2026
Barclays44,0450.16%US$970K+11,699Nov 6, 2026
Wells Fargo43,6480.16%US$961K−15,697Nov 16, 2026
American Century38,4430.14%US$847K−206Nov 20, 2026

This page holds 50 of 138 holders. Open Shareholders

Funds

HolderSharesOf the companyValueChangeAs of
Vanguard Total Stock Market Index Fund552K2.0%US$11.3M−72,900Jun 30, 2026
iShares Russell 2000 ETF514K1.8%US$10.5M+7,527Jun 30, 2026
Columbia Small Cap Value Discovery Fund397K1.4%US$6.56M+24,200Jul 31, 2026
BlackRock Advantage Small Cap Core Fund306K1.1%US$5.55M−3,800May 29, 2026
Invenomic Fund263K0.94%US$4.35M−201KJul 31, 2026
Vanguard Extended Market Index Fund218K0.78%US$4.46M−14,842Jun 30, 2026
Fidelity Small Cap Index Fund213K0.76%US$3.52M+4,454Jul 31, 2026
iShares Russell 2000 Value ETF179K0.64%US$3.67M−3,568Jun 30, 2026
Schwab Fundamental U.S. Small Company ETF135K0.48%US$2.45M−55,760May 31, 2026
iShares Biotechnology ETF129K0.46%US$2.65M−19,830Jun 30, 2026
Show 50 holders
HolderSharesOf the companyValueChangeAs of
U.S. Small Cap Portfolio123K0.44%US$2.03M+21,403Jul 31, 2026
Fidelity Extended Market Index Fund110K0.39%US$2M+2,606May 31, 2026
Vanguard Russell 2000 Index Fund108K0.39%US$1.95M+5,167May 31, 2026
U.S. Micro Cap Portfolio103K0.37%US$1.7M+1,990Jul 31, 2026
Multi-Manager Small Cap Equity Strategies Fund101K0.36%US$1.84MNewMay 31, 2026
Strategic Advisers U.S. Total Stock Fund101K0.36%US$1.84M+14,586May 31, 2026
PIMCO RAE US Small Fund99,5560.36%US$2.04M−24,723Jun 30, 2026
Schwab U.S. Small-Cap ETF96,7620.35%US$1.76M−1,526May 31, 2026
Dimensional U.S. Small Cap ETF72,3990.26%US$1.2M−24,449Jul 31, 2026
Dimensional U.S. Core Equity 2 ETF72,2790.26%US$1.2M−12,294Jul 31, 2026
Columbia Variable Portfolio - Small Cap Value Discovery Fund71,7520.26%US$1.47M−2,500Jun 30, 2026
NVIT Multi-Manager Small Company Fund68,0610.24%US$1.4M+29,198Jun 30, 2026
NVIT Small Cap Value Fund62,8940.23%US$1.29M+25,873Jun 30, 2026
Small Cap Equity Fund60,3170.22%US$1.24M+15,157Jun 30, 2026
Vanguard Health Care Index Fund59,3070.21%US$1.08M−506May 31, 2026
State Street(R) SPDR(R) S&P(R) Health Care Services ETF51,2310.18%US$1.05M+9,169Jun 30, 2026
Goldman Sachs Small Cap Value Insights Fund49,7110.18%US$823KNewJul 31, 2026
Schwab Small-Cap Index Fund48,0070.17%US$795K+2,139Jul 31, 2026
iShares ESG Aware MSCI USA Small-Cap ETF47,5780.17%US$863K+10,052May 31, 2026
Federated Hermes MDT Market Neutral Fund46,4790.17%US$954KNo changeJun 30, 2026
Invesco RAFI US 1500 Small-Mid ETF41,8170.15%US$692K−1,806Jul 31, 2026
Schwab Fundamental U.S. Small Company Index Fund38,5700.14%US$638K+2,742Jul 31, 2026
Fidelity Total Market Index Fund38,1510.14%US$692KNo changeMay 31, 2026
Avantis U.S. Small Cap Equity ETF36,7690.13%US$667K−7,117May 31, 2026
iShares U.S. Healthcare Providers ETF36,1650.13%US$742K+11,901Jun 30, 2026
U.S. Core Equity 2 Portfolio34,8910.12%US$577K−8,700Jul 31, 2026
Master Small Cap Index Series34,7310.12%US$713KNo changeJun 30, 2026
Counterpoint Tactical Equity Fund34,3060.12%US$704KNo changeJun 30, 2026
ALPS Medical Breakthroughs ETF32,1910.12%US$584K+4,637May 31, 2026
Fidelity Series Total Market Index Fund31,0290.11%US$563K+1,542May 31, 2026
U.S. Core Equity 1 Portfolio28,4660.10%US$471K−6,300Jul 31, 2026
Fidelity Small Cap Value Index Fund27,2480.10%US$559K+1,039Jun 30, 2026
Nuveen Small Cap Blend Index Fund24,3880.09%US$404KNo changeJul 31, 2026
EQ/2000 Managed Volatility Portfolio21,3070.08%US$437KNo changeJun 30, 2026
U.S. Small Cap Value Portfolio21,2030.08%US$351KNo changeJul 31, 2026
Fidelity Nasdaq Composite Index Fund19,6560.07%US$357KNo changeMay 31, 2026
Diversified Equity Alpha Master Portfolio17,5680.06%US$360K−5,640Jun 30, 2026
Vanguard Russell 2000 Value Index Fund16,9670.06%US$308K+1,898May 31, 2026
Nuveen Equity Index Fund16,1080.06%US$267KNo changeJul 31, 2026
JPMorgan Small Cap Value Fund16,1040.06%US$330K−982Jun 30, 2026

This page holds 50 of 165 holders. Open Shareholders

Insider trades

InsiderTradeSharesPriceValueDate
Gao Hanlin
Officer: Chief Scientific Officer
Sale1,673USD 19.66US$32,891Sep 2, 2026
Xie Jian
Officer: President and COO
Sale2,127USD 19.66US$41,817Sep 2, 2026
Gao Hanlin
Officer: Chief Scientific Officer
Sale939USD 19.91US$18,695Aug 27, 2026
Xie Jian
Officer: President and COO
Sale1,193USD 19.91US$23,753Aug 27, 2026
Gao Hanlin
Officer: Chief Scientific Officer
Sale1,688USD 17.89US$30,198Jun 2, 2026
Xie Jian
Officer: President and COO
Sale2,146USD 17.89US$38,392Jun 2, 2026
Gao Hanlin
Officer: Chief Scientific Officer
Sale945USD 17.60US$16,632May 27, 2026
Xie Jian
Officer: President and COO
Sale1,201USD 17.60US$21,138May 27, 2026

Big stakes

HolderStakeSharesDate
Ming Hsieh32.26%8.87MMay 22, 2026
Barclays PLC7.57%2.34MMar 31, 2025
BlackRock, Inc.5.90%1.82MMar 31, 2025

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
John C Bolger
Other companies: Tintri Inc (Director · Jun 29, 2017 – Jun 29, 2017 · Past); Mission West Properties Inc (Director · Jan 12, 2007 – Jan 2, 2008 · Past); Mattson Technology Inc (Director · Dec 12, 2006 – Jul 26, 2010 · Past); Integrated Device Technology Inc (Director · Nov 15, 2006 – Nov 15, 2007 · Past); Wind River Systems Inc (Director · Apr 1, 2006 – Jul 16, 2009 · Past)
Director · Sep 28, 2016 – Aug 1, 2022 · Past
Leonard Post
Other companies: CG Oncology, Inc. (Chief Scientific Officer, Vivace Therapeutics · Since at least Jan 24, 2024); uniQure N.V. (Director · Since at least Jun 17, 2020); Praecis Pharmaceuticals Inc (Director · Feb 7, 2007 – Feb 7, 2007 · Past)
Director · Aug 1, 2022 – Aug 1, 2022 · Past
James Mulay
Other companies: CG Oncology, Inc. (Director · Since at least Jan 24, 2024)
Director · Sep 28, 2016 – May 30, 2019 · Past
Linda Dong
Other companies: Astrana Health Inc. (Director · Since at least Jan 11, 2019)
Director · Since at least Aug 1, 2019
Ming Hsieh
Other companies: Fortinet, Inc. (Director · Since at least Nov 6, 2017)
Chairman of our Board of Directors and Chief Executive Officer · Since at least Nov 9, 2017
Paul Kim
Other companies: Exagen Inc. (Board Member · Since at least Jul 24, 2023)
CFO and Treasurer · Since at least Aug 12, 2016
Regina E. Groves
Other companies: AtriCure, Inc. (Director · Since at least Mar 21, 2017)
Director · Since at least Jan 3, 2023
Yun Yen
Other companies: Lixte Biotechnology Holdings, Inc. (Director · Since at least Nov 30, 2020)
Director · Sep 28, 2016 – May 18, 2022 · Past
Hanlin GaoChief Scientific Officer · Since at least May 13, 2016
Jian XiePresident and COO · Since at least Aug 3, 2020
All 13 people
PersonSeat
Linda MarshDirector · Since at least Nov 5, 2026
Michael NohaileDirector · Since at least Aug 1, 2022
Reggie GrovesDirector · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Fulgent Genetics, Inc.